Find the Perfect Plan for Your Investment Journey
R
Latest price
52 Week Range
€21.35 - €35.84
Next Earnings Date
Apr 29 2025
Next Earnings Date
Apr 29 2025
Latest price
Market Cap | €627.73M |
EV | €619.83M |
Shares Outstanding | 26.60M |
Beta | 1.48 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | €30.88 |
P/E 2025E | 26.92x |
P/Revenue 2025E | 5.53x |
Revenue | 9.50% |
EPS | 3.40% |
Operating Cash Flow | 3.60% |
Free Cash Flow | 35.00% |
Revenue | 12.10% |
EPS | 21.80% |
Operating Cash Flow | 17.50% |
Free Cash Flow | 19.50% |
Gross Margin 2025E | 70.73% |
Net Profit Margin 2025E | 20.40% |
ROE 2025E | 20.24% |
ROCE 2024 | 17.82% |
DPS 2025E | €0.43 |
Payout Ratio 2025E | 48.86% |
Div. Yield 2025E | 1.82% |
DPS Last 3Y CAGR | 5.60% |
Price
%
1M
3M
6M
1Y
3Y
5Y
R
Revenio Group Oyj
REG1V
Sector
Healthcare
Industry
Medical - Devices
CEO
Toijala, Jouni
Employees
241
Website
www.reveniogroup.fiIPO Date
2001-10-02
Headquarters
Aeyritie 22, Vantaa, Uusimaa, 01510, Finland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved